Nanomedicine: Nanotechnology, Biology and Medicine
Volume 8, Issue 2 , Pages 131-135, February 2012

HPV infections: Can they be eradicated using nanotechnology?

  • Marianna Foldvari, PhD

      Affiliations

    • Corresponding Author InformationCorresponding author: University of Waterloo, School of Pharmacy, Waterloo Institute of Nanotechnology, 200 University Avenue West, Waterloo, ON, Canada N2L 3G1.
    • The author is the inventor of biphasic vesicle (Biphasix) technology, founder of PharmaDerm Laboratories Ltd., acquired by Helix BioPharma Corp., developing the Biphasix technology.

Received 25 October 2011; accepted 4 November 2011. published online 18 November 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1549-9634(11)00526-0

doi:10.1016/j.nano.2011.11.006

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 8, Issue 2 , Pages 131-135, February 2012

Article Tools

* Image Usage & Resolution